Ablation
is surgical removal of a body tissue in the form of transferring heat to the
end tissue. It is used to remove an insignificant or large extent of tissue.
There are several types of ablations and have numerous techniques to perform the
removal of tissue depending on the type of tissue. The operational needle is inserted
near the site with image guided modalities for instance ultrasonography,
computed tomography (CT) and magnetic resonance imaging (MRI).Some of the products
are Barrx radio frequency ablation system, Cardioblate 68000 surgical ablation
system generator, Endostat III Bipolar or Monopolar electrosurgical generator, CARTO
3 system, AtriCure Ablation Sensing Unit (ASU), THERMOCOOL Bi-Directional
Catheter and Cardioblate MAPS device.
According
to study, “Global Ablation Devices Market -
Drivers, Opportunities, Trends, and Forecasts: 2017-2023” the major companies operating
in the global ablation devices market are Boston Scientific Corp., AtriCure,
Inc., Stryker Corp., Abott Laboratories, EDAP TMS S.A., AngioDynamics,Olympus
Corp., Bausch and Lomb, CONMED Corp., Smith & Nephew plc., Elekta AB, Medtronic
Plc., Terumo Corporation, Galil Medical Inc., Integra Lifesciences Holdings
Corporation, Hologic Inc., C.R. Bard Inc., Varian Medical Systems Inc., Accuray
Incorporated, Japan Lifeline Co. Ltd., Halyard Health, Inc., Misonix Inc., MedWaves,
Inc., St. Jude Medical, Inc., BTG plc, Johnson & Johnson.
Based
on product, the market is segmented into ablation catheters, generators or electrosurgical
units and consumables. Based on technology market is segmented into thermal
ablation and non thermal ablation. Thermal ablation is further sub-segmented
into radio frequency ablation, EBRT, radiation ablation (stereotactic radio
surgery devices, brachytherapy, stereotactic body radiotherapy devices, image
modulated radiotherapy (IMRT), image guided radiotherapy (IGRT), proton beam
therapy, nano radiation therapy), laser based ablation, ultrasound ablation,
cryoablation, microwave ablation and hydrothermal ablation. Non-thermal
ablation is sub-segmented into mechanical ablation technology and
electroporation ablation technology. Based on procedure, market is segmented
intobenign prostatic hyperplasia, stress urinary incontinence, transurethral needle
ablation, aesthetics-skin rejuvenation & tightening, menorrhagia/endometrial
ablation, atrial fibrillation, varicose veins, tumor ablation, spinal
decompression & denervation,uterine fibroids and laser & other energy
based therapies or holmium laser ablation.
Based
on function market is segmented into conventional and robotic or automated
ablation devices.By application, the market is segmented into general surgery, urology,
oncology, orthopedic, Atrial Fibrilation (AF/AFIB), pain management, cosmetology,
cardiovascular and
gynecology etc. The end user segments include ambulatory surgical centers,
hospitals and physician’s office or specialty clinics etc.
The
market of ablation devices is driven by rise in elderly population, followed by
increasing popularity of MI surgeries, development repayment scenario in
established markets, increasing market awareness & campaigns, expanding funding
for the development of novel ablation device, rise in the prevalence of chronic
disorders (atrial flutter, atrial fibrillation (AF), and cardiac arrhythmias),
and increase in disposable income. However some of the restraints are high cost
of ablation procedures, complication & risk associated with ablation
procedures, lack of skilled electrophysiologists and stringent regulatory
approval process etc. Additionally, some of the new opportunities are high demand
of lasers in ablation techniques shifts towards minimal & non-invasive
procedures, increasing healthcare spending and technological advancements. It
is estimated that the future of the market is bright owing to increase in the
number of outpatient procedures.
To
know more, click on the link below:-
Related
Report:
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
